๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsing Multiple Sclerosis

Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis NCT07220252Phase 2, Phase 36 sites๐Ÿ“ Salt Lake City๐Ÿ“ Gdansk๐Ÿ“ Poznan TG Therapeutics, Inc. ยท Tests: Ublituximab, Placebo, Placebo, Fingolimod A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis NCT07827716Phase 21 site๐Ÿ“ Wuhan Chuan Qin ยท Tests: Terfenadine, Standard First-line Disease-Modifying Therapy Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis NCT05748015NA2 sites๐Ÿ“ Telese Terme๐Ÿ“ Naples Istituti Clinici Scientifici Maugeri SpA ยท Tests: quantification of sensory and autonomic small nerve fibers by punch skin biopsy, Cardiovascular Reflexes testing, Adminโ€ฆ A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis NCT07321093Phase 31 site๐Ÿ“ Nizhny Novgorod Biocad ยท Tests: BCD-281, Ocrelizumab A Study Evaluating the Real World Experience of Participants Treated With BRIUMVIยฎ (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) NCT06433752n/a113 sites๐Ÿ“ Birmingham๐Ÿ“ Cullman๐Ÿ“ Huntsville TG Therapeutics, Inc. ยท Tests: No Intervention Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis NCT05964829NA1 site๐Ÿ“ Cleveland Cionic, Inc. ยท Tests: Cionic Neural Sleeve NS-100, Walking Program A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis NCT05906992Phase 31 site๐Ÿ“ Poznan Celltrion ยท Tests: CT-P53, US-Ocrevus, EU-Ocrevus Safety and Efficacy Study of Fingolimod in Taiwanese Adults (โ‰ฅ 20years) With Relapsing Remitting Multiple Sclerosis NCT04480853Phase 46 sites๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung๐Ÿ“ Tainan Novartis Pharmaceuticals ยท Tests: Fingolimod Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands NCT06567197n/a2 sites๐Ÿ“ Amsterdam๐Ÿ“ Nieuwegein Amsterdam UMC, location VUmc A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis NCT07826689Phase 1, Phase 21 site๐Ÿ“ Adelaide Progentos Therapeutics ยท Tests: PRO-1562 Oral Capsules, Placebo Oral Capsule Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study NCT07376772NA2 sites๐Ÿ“ Gainesville๐Ÿ“ Gainesville University of Florida ยท Tests: wearable focal vibration therapy REAL-MS: Observational Database Study of AHSCT and MS Therapies NCT07899502n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ London Imperial College London ยท Tests: Autologous haematopoietic stem cell transplantation (AHSCT), High-efficacy disease-modifying therapy (HE-DMT) RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies NCT06267781n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment NCT07304154Phase 110 sites๐Ÿ“ Newport Beach๐Ÿ“ Palo Alto๐Ÿ“ New York Kite, A Gilead Company ยท Tests: KITE-363, Fludarabine, Cyclophosphamide Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity NCT07292480NA2 sites๐Ÿ“ Nice๐Ÿ“ Nรฎmes Centre Hospitalier Universitaire de Nฤซmes ยท Tests: Monthly pNfL monitoring Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) NCT06526364n/a1 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: All participants will be asked to provide data and samples for collection and analysis. Sexual Dysfunction in Women With Multiple Sclerosis (MS) NCT07193823n/a1 site๐Ÿ“ Izmir Ege University Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation NCT05958381NA1 site๐Ÿ“ Richardson The University of Texas at Dallas ยท Tests: Transcranial Direct Current Stimulation, Sham transcranial direct current stimulation CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785EARLY Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis NCT03401879NA1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Dynamic Vessel Analyzer (DVA), Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Optical coherence tomographโ€ฆ Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. NCT06846281Phase 3131 sites๐Ÿ“ Scottsdale๐Ÿ“ Irvine๐Ÿ“ Washington D.C. Novartis Pharmaceuticals ยท Tests: Remibrutinib oral treatment, Ocrelizumab Postoperative Relapses in MS Patients NCT04237675n/a2 sites๐Ÿ“ Athens๐Ÿ“ Athens University of Athens ยท Tests: surgery and anesthesia Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis NCT07827586n/a2 sites๐Ÿ“ Pardubice๐Ÿ“ Ljubljana Hoffmann-La Roche ยท Tests: Ocrelizumab A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to โ‰ค55 Years NCT06735248Phase 217 sites๐Ÿ“ Boston๐Ÿ“ Farmington Hills๐Ÿ“ Ozark ModernaTX, Inc. ยท Tests: mRNA-1195, Placebo A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS) NCT06681623n/a1 site๐Ÿ“ Foxborough Neurology Center of New England P.C. ยท Tests: Ublituximab Multiple Sclerosis and the Effects of Ketogenic Diet Therapy NCT06715436NA1 site๐Ÿ“ Pavia IRCCS National Neurological Institute "C. Mondino" Foundatiโ€ฆ ยท Tests: Mediterranean Diet, Ketogenic Diet, Control group Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) NCT07360977NA1 site๐Ÿ“ Messina IRCCS Centro Neurolesi Bonino Pulejo ยท Tests: bioactivated GRA for adult patients, bioactivated GRA for pediatric patients MS-ResearchBiomarkerS NCT05204459n/a1 site๐Ÿ“ Los Angeles Cedars-Sinai Medical Center REtinal Markers In Neuroinflammatory Diseases ("REMIND") NCT06369766n/a1 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: Optical coherence tomography (OCT), Static retinal vessel analyzer, Dynamic retinal vessel analyzer, Laser speckle flowโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy